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Abstract Couples with fertility problems seeking treatment
with assisted reproductive technologies (ART) such as in
vitro fertilization should receive preconception counseling
on all factors that are provided when counseling patients
without fertility problems. Additional counseling should ad-
dress success rates and possible risks from ART therapies.
Success rates from ART are improving, with the highest live
birth rates averaging about 40% per cycle among women
less than 35 years old. A woman’s age lowers the chance of
achieving a live birth, as do smoking, obesity, and infertility
diagnoses such as hydrosalpinx, uterine leiomyoma, or male
factor infertility. Singletons conceived with ART may have
lower birth weights. Animal studies suggest that genetic im-
printing disorders may be induced by certain embryo culture
conditions. The major risk from ovarian stimulation is mul-
tiple gestation. About one-third of live-birth deliveries from
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ART have more than one infant, and twins represent 85% of
these multiple-birth children. There are more complications
in multiple gestation pregnancies, infants are more likely to
be born preterm and with other health problems, and fami-
lies caring for multiples experience more stress. Transferring
fewer embryos per cycle reduces the multiple birth rate from
ART, but the patient may have to pay for additional cycles
of ART because of a lower likelihood of pregnancy.
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Current knowledge
Fertility problems affect about 10% of couples in developed
countries [1–3]. These couples should receive preconception
counseling on all factors that are discussed during preconcep-
tion counseling for patients without fertility problems. Addi-
tional counseling should address success rates and possible
risks from the specific fertility treatments being considered
because of the couple’s diagnoses and preferences. To pro-
vide an example of an approach to preconception counseling
for the infertile couple, treatment with assisted reproductive
technologies (ART) such as in vitro fertilization (IVF) is
reviewed here.
About 1% of births in the United States are the result of
ART [4]. ART care represents a unique opportunity for pre-
conception counseling because the moment of conception
is easily discernable. Counseling should address expected
success rates from ART based on the woman and the man’s
risk profile. Older maternal age is the strongest risk factor
for not achieving a successful outcome from ART. Live birth
rates average about 40% per cycle among women less than
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35 years old, and gradually decrease to about 6% per cy-
cle among women over age 42 who use their own oocytes
[4]. Older women who accept donor oocytes increase their
chance of a live birth to approximately the rate seen in the
age group of the donor woman [5]. Cumulative live birth
rates account for the fact that many couples return for fur-
ther treatment if the first cycle of ART is unsuccessful. For
couples who complete two to three ART cycles, cumulative
live birth rates are about 50–60% for women 35 years old or
younger, declining to about 30% by age 40 [6]. As men’s age
increases, the time required for a couple to conceive length-
ens, even after controlling for the woman’s age and other
risk factors for reduced fertility [7].
The chance of having a live birth from ART therapy
is influenced by the health habits and the infertility diag-
noses of the couple. Current tobacco smoking by women
decreases ovarian function and is manifested by increased
basal levels of follicle stimulating hormone. Such women
produce fewer oocytes during ART and have lower preg-
nancy rates [8, 9]. Current smoking by the male partner also
decreases pregnancy rates through direct effects on sperm
and by exposing the woman partner to side-stream smoke. In-
creasing body mass index (BMI) is associated with decreas-
ing ovarian response to follicle stimulating hormone, result-
ing in fewer oocytes collected in a given IVF cycle, as well
as increasing rates of early pregnancy loss [10]. Although no
strong evidence associates underweight with adverse ART
outcomes, maternal underweight (BMI < 18.5 kg/m2) is risk
factor for low birth weight in the general population.
As the number of specific infertility diagnoses increases
for a couple, pregnancy and live birth rates from ART de-
crease. Moreover, certain infertility diagnoses are somewhat
more difficult to overcome than others during treatment. Live
birth rates after ART tend to be slightly higher if the only
diagnosis is endometriosis, and slightly lower if the only
diagnosis is uterine leiomyoma or hydrosalpinx [4, 6, 11].
Leiomyoma may decrease uterine receptivity, mainly when
an intramural or submucosal fibroid distorts the endome-
trial cavity. The mechanism by which hydrosalpinx wors-
ens the prognosis in ART is not understood, but tubal fluid
in hydrosalpinx has embryotoxic properties and salpingec-
tomy improves live birth rates [12]. Male factor infertility is
present in about 40% of couples presenting for ART, and may
be a barrier to achieving pregnancy unless intracytoplasmic
sperm injection (ICSI) is used [4, 6, 11].
The most common adverse outcome from infertility treat-
ment is multiple gestation. ART produced 11,544 multiple
birth deliveries in the United States during 2002 [4]. Of all the
ART infants born that year, 45.7% were twins and 7.6% were
triplets or higher order multiples. Although health outcomes
are good to excellent in many twin pregnancies, mothers of
twins experience more pregnancy complications, lasting in-
fant neurologic impairment may occur from very preterm
birth, and the neonatal death rate of twins is 5–10 times
greater than of singletons. For triplets, 90% of births are
preterm and the relative risk of death in the first month of
life is increased 20-fold [13].
To place the risk of multiple gestation from ART in per-
spective, estimates are available on the proportion of multiple
births from unassisted conception and from treatment with
ovulation medications without ART. These estimates have
been made by subtracting the rate of multiple births during
the era before ovulation-inducing drugs (unassisted concep-
tion) and the rate of multiple births resulting from ART
from the total rate of multiple births, adjusted for trends in
maternal age [4, 14]. Such an analysis shows that about 65%
of twins and 15–18% of triplets are from natural conception
each year. About 20% of twins and 35–40% of triplets are
probably from ovulation induction without ART, and about
15% of twins and 40–45% of triplet births result from ART
[14].
In general, women with the best prognosis for achieving
a live birth from ART are younger than 35 years, use freshly
fertilized embryos from their own eggs, and have good qual-
ity embryos—a marker of the latter is having more embryos
available than are transferred. For this group, recent surveil-
lance statistics showed that transferring one, two, three or
four embryos resulted in live birth rates of 47.4, 51.8, 49.6
and 45.5%, respectively; the singleton rates among these
births were 100.0, 60.4, 52.8 and 40.7%, respectively [4]. By
age 38–40 years the prognosis is poorer among all women
who use freshly fertilized embryos from their own eggs.
Transferring one, two, three or four embryos in this group
resulted in live birth rates of 10.4, 23.3, 28.9 and 29.9% re-
spectively; the singleton rates among these births were 97.4,
81.2, 79.2 and 70.4%, respectively. Thus, for women with
the best prognosis, transferring more embryos provides little
improvement in live birth rates with an increasing risk of
multiples. For women with a poorer prognosis, additional
embryos may improve live birth rates up to a point, and the
risk for multiples may increase less dramatically [4].
During ART, ovarian hyperstimulation syndrome is as-
sociated with production of a large number of follicles.
Usually the only symptoms are modest abdominal pain.
More severely affected women, however, experience in-
creased capillary permeability that leads to ascites and in
rare cases, death. Symptoms requiring hospitalization occur
in 0–3% of IVF cycles [15]. Ovarian cancer risk from med-
ications used to stimulate folliculogenesis has been studied
because of concerns that this treatment may trigger growth
of ovarian cortical cells through the process of healing at
the sites of ovulation. Although studies show that women
treated with ART have about a 50% increase in ovarian can-
cer risk compared to the general population, when compared
to control women with infertility who did not receive ART,
ovarian cancer risk is not elevated [16]. Thus it appears that
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infertility itself may be the risk factor for ovarian cancer,
rather than ART.
Singletons conceived with ART may be at greater risk
of being born prematurely, or to be small for gestational
age [17]. Available studies have been limited by lack of
data on key confounders. When matching is used to con-
trol for the most important confounders, the risk difference
between spontaneously conceived singletons and singletons
conceived with ART remains, but appears to be relatively
small. The rates of fetal growth restriction differ by about
3.7%, with an overall rate of growth restriction of 8.6%
among spontaneous singletons compared to a rate of 12.3%
among singletons conceived with ART. The rates of very
preterm birth differ by about 1.3%, with an overall rate of
very preterm birth of 0.7% for spontaneous singletons com-
pared to 2.0% for singletons conceived with ART [17].
In some studies, an increased risk of birth defects has been
noted among IVF children compared to the general popula-
tion, but in other studies the difference tends to disappear
when risk factors for both infertility and birth defects such
as older parental age and multiple gestation are controlled
[18]. Infertility is sometimes caused by sex chromosome
aberrations, such as Y chromosome deletions that lead to
reduced sperm counts in men [18, 19]. Sperm of men with
reduced fertility has more aneuploidy [20]. Whether treat-
ment of male factor infertility by ICSI will cause fertility
problems in male offspring cannot be known until long-term
follow-up is available.
Adverse embryo culture conditions can cause imprint-
ing disorders in mice during a procedure similar to ART.
This lends biologic plausibility to imprinting disorders as
a possible adverse effect of IVF [18, 19, 21]. Imprinting
is the mechanism by which congenital disorders such as
Beckwith-Wiedemann syndrome, Angelman syndrome and
Prader-Willi syndrome occur. These syndromes have been
reported in children conceived with ART, although the rarity
of the syndromes and problems generalizing from animal
experiments to humans makes a causal relationship difficult
to establish. In an Australian study that used data from a
national genetics testing laboratory, 37 cases of Beckwith-
Wiedemann syndrome occurred in 1.3 million live births, a
rate of one in every 35,580 births [22]. Four of the cases were
associated with IVF compared to a matched control group
in which one mother had IVF (P < 0.05). In a cohort study
from the Danish national registries for IVF and for all births,
however, no increase in imprinting diseases was linked to
ART [23].
Recommendations for action
Reproductive endocrinologists use a combination of clinical
factors to advise couples of the likelihood of success from
infertility treatment, and they use clinical tests such basal
follicle stimulating hormone levels to further characterize
prognosis. Professional practice guidelines are available that
recommend transferring fewer embryos among the couples
with greatest risk for multiple gestation [24].
Professional guidelines note the elements to be considered
when educating patients during the informed consent pro-
cess for ART [25]. Reproductive endocrinologists routinely
counsel patients about the risks from ART, including multi-
ple gestation, ovarian hyperstimulation syndrome, physical
injury during procedures, and success rates [26]. It may be
prudent to counsel patients about emerging scientific issues
as new research is published, such as concerns about em-
bryo culture and ICSI. This would be similar to the approach
used for other potential concerns. That is, even though a
causal relationship between ART treatment methods and de-
velopment of ovarian cancer has not been substantiated, the
majority of reproductive endocrinologists inform patients of
the issue [26].
Effectiveness of interventions
Little research exists on comprehensive preconception coun-
seling for infertility patients. Studies that have examined
counseling about the most common adverse outcome, multi-
ple births, have found that many infertility patients prefer to
have twins and sometimes triplets rather than a single infant
[27–29]. A randomized trial of a new educational interven-
tion was ineffective at reducing this preference, although
other research has found that raising awareness of the risks
of multiple births reduces patient preference for multiples
[27, 28].
Integration with other preconception services
Routine preconception counseling for women and men
should include information on the many well-documented
risk factors for experiencing infertility later in life. When
patients who have trouble conceiving present for ART, rein-
forcing these concepts and combining preconception care at
the key decision-making points should help maximize health
outcomes for parents and their future children.
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